CD80 and COVID-19: To evaluate the relevance of CD80/86 co-stimulation in the lungs during COVID-19 we took advantage of an available single-cell RNA-seq dataset generated from the bronchoalveolar lavage fluid obtained from mild (n = 3) and severe (n = 6) COVID-19 patients and from healthy controls (n = 3)10,11.